Surrozen, Inc./DE Capital Expenditures
Surrozen, Inc./DE (SRZN) reported Capital Expenditures of $139.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Surrozen, Inc./DE payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $19.00K, a 5.56% increase year-over-year.
- Surrozen, Inc./DE payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $120.00K, a 344.44% increase year-over-year.
- Surrozen, Inc./DE payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $59.00K, a 210.53% increase year-over-year.
- Surrozen, Inc./DE payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $24.00K.
- Surrozen, Inc./DE payments to acquire property, plant, and equipment for fiscal 2025 was $128.00K, a 392.31% increase from fiscal 2024.
- Surrozen, Inc./DE payments to acquire property, plant, and equipment for fiscal 2024 was $26.00K, a 93.47% decline from fiscal 2023.
- Surrozen, Inc./DE payments to acquire property, plant, and equipment for fiscal 2023 was $398.00K, a 45.33% decline from fiscal 2022.
- Surrozen, Inc./DE payments to acquire property, plant, and equipment for fiscal 2022 was $728.00K, a 42.63% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $139.00K 10-Q · filed 2026-08-06 | $198.00K derived: sum of 3 quarters · filed 2026-08-06 | $222.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $120.00K 10-Q · filed 2026-05-06 | $179.00K derived: sum of 2 quarters · filed 2026-05-06 | $203.00K derived: sum of 3 quarters · filed 2026-05-06 | $221.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $83.00K derived: sum of 2 quarters · filed 2026-03-23 | $101.00K derived: sum of 3 quarters · filed 2026-08-06 | $128.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $42.00K derived: sum of 2 quarters · filed 2026-08-06 | $69.00K 10-Q · filed 2025-11-07 | $88.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $45.00K 10-Q · filed 2026-08-06 | $64.00K derived: sum of 3 quarters · filed 2026-08-06 | $64.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $27.00K 10-Q · filed 2026-05-06 | $46.00K derived: sum of 2 quarters · filed 2026-05-06 | $46.00K derived: sum of 3 quarters · filed 2026-05-06 | $46.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $19.00K derived: sum of 2 quarters · filed 2026-03-23 | $19.00K derived: sum of 3 quarters · filed 2026-03-23 | $26.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $7.00K 10-Q · filed 2025-11-07 | $7.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $7.00K 10-Q · filed 2025-08-08 | $7.00K derived: sum of 3 quarters · filed 2025-08-08 | $7.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $7.00K 10-Q · filed 2025-05-09 | $7.00K derived: sum of 2 quarters · filed 2025-05-09 | $7.00K derived: sum of 3 quarters · filed 2025-05-09 | $90.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $83.00K derived: sum of 3 quarters · filed 2025-03-31 | $398.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $83.00K derived: sum of 2 quarters · filed 2024-11-06 | $398.00K 10-Q · filed 2024-11-06 | $546.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $398.00K 10-Q · filed 2024-08-12 | $546.00K derived: sum of 3 quarters · filed 2024-08-12 | $691.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $315.00K 10-Q · filed 2024-05-08 | $463.00K derived: sum of 2 quarters · filed 2024-05-08 | $608.00K derived: sum of 3 quarters · filed 2024-05-08 | $631.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $293.00K derived: sum of 2 quarters · filed 2024-04-10 | $316.00K derived: sum of 3 quarters · filed 2024-04-10 | $728.00K 10-K · filed 2024-04-10 |
| 2022-09-30 | $145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $168.00K derived: sum of 2 quarters · filed 2023-11-08 | $580.00K 10-Q · filed 2023-11-08 | $904.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $435.00K 10-Q · filed 2023-08-09 | $759.00K derived: sum of 3 quarters · filed 2023-08-09 | $1.30M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $412.00K 10-Q · filed 2023-05-10 | $736.00K derived: sum of 2 quarters · filed 2023-05-10 | $1.28M derived: sum of 3 quarters · filed 2023-05-10 | $1.34M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $865.00K derived: sum of 2 quarters · filed 2023-03-31 | $926.00K derived: sum of 3 quarters · filed 2023-03-31 | $1.27M 10-K · filed 2023-03-31 |
| 2021-09-30 | $541.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $602.00K derived: sum of 2 quarters · filed 2022-11-14 | $945.00K 10-Q · filed 2022-11-14 | $1.41M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $404.00K 10-Q · filed 2022-08-11 | $864.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $343.00K 10-Q · filed 2022-05-11 | $803.00K derived: sum of 2 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $874.00K 10-K · filed 2022-03-28 | ||
| 2020-09-30 | $414.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |